Non-Hodgkin's lymphoma and proteinuria

被引：0

作者：

Galle J. ^{[1
]}

Helmchen U. ^{[2
]}

Heil G. ^{[3
]}

Kalb K. ^{[1
]}

机构：

[1] Nephrologie und Dialyseverfahren, Klinikum Lüdenscheid, 58515 Lüdenscheid

[2] Nierenregister am Institut für Pathologie, Universitätsklinikum Hamburg-Eppendorf

[3] Hämatologie und Onkologie, Klinikum Lüdenscheid

来源：

Der Nephrologe | 2010年 / 5卷 / 4期

关键词：

Membranoproliferative glomerulonephritis; Non-Hodgkin's lymphoma; Proteinuria; Rituximab;

D O I：

10.1007/s11560-010-0409-2

中图分类号：

学科分类号：

摘要：

Membranoproliferative glomerulonephritis type I is rarely found as a primary idiopathic disease. More frequently it occurs in associa-tion with various underlying diseases, includ-ing autoimmune disorders such as systemic lupus erythematosus, cryoglobulinemia, chronic infections, and malignancies. Para-neoplastic glomerulopathy can be seen asso-ciated with chronic lymphocytic leukaemia in particular. We present a case of secondary membranoproliferative glomerulonephritis and non Hodgkin's lymphoma of B cell type and show how treatment for the underlying disease - in this patient a single course of rituximab/bendamustin - led to complete recovery from renal manifestations of the lymphoma but also nearly complete recovery from the secondary glomerulonephritis. Copyright © Springer-Verlag 2010.

引用

页码：314 / 318

页数：4

共 4 条

[1]

Rennke H.G., Secondary membranoproliferative glomerulonephritis, Kidney Int, 47, pp. 643-656, (1995)

[2]

Ronco P.M., Paraneoplastic glomerulopathies: New insights into an old entity, Kidney Int, 56, pp. 355-377, (1999)

[3]

Moulin B., Ronco P.M., Mougenot B., Et al., Glomerulonephritis in chronic lymphocytic leukemia and related B-cell lymphomas, Kidney Int, 42, pp. 127-135, (1992)

[4]

Meerten Van T., Hagenbeek A., CD20-targeted therapy: A breakthrough in the treatment of non-Hodgkin's lymphoma, Neth J Med, 67, pp. 251-259, (2009)

← 1 →